Delivery Order SPE2DB20D1109-SPE2DB25FN82W

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML. The contract has a ceiling value of $6,104.76 and a period of performance through June 18, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $1,017.58 and a performance period ending on June 24, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $3,676.85. The contract is a firm fixed-price, non-set-aside award with a completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product, with a ceiling value of $1,017.58 and a performance period through June 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTOR, a medication, with a ceiling value of $3,052.38 and a completion date of May 30, 2025. The contract is a firm-fixed-price delivery order, and is not a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $1,017.46. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,561.46 contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of June 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Aimovig 70 mg/ml autoinjectors, with a ceiling value of $7,134.56 and a period of performance through April 18, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication, to support federal healthcare programs. The contract has a ceiling value of $10,572.09 and is a firm fixed price, delivery order type contract with a period of performance through February 2025. The contract was not set...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a prescription medication, with a ceiling value of $13,887.80. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN82W
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $7,893.34 and a period of performance through April 3, 2025. The contract is a firm-fixed-price delivery order, which indicates the product is being procured for a predetermined price. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/2/25, 10:46 PM